Curetis listing anniversary

Curetis celebrates one year listed anniversary

Curetis (ticker symbol: CURE) celebrates its one-year listed anniversary at Euronext by sounding the gong. Oliver Schacht, CEO Curetis, visits Beursplein 5 and sounds the gong. 

Founded in 2007, Curetis is a molecular diagnostics company which focuses on the development and commercialization of reliable, fast and cost-effective products for diagnosing severe infectious diseases.

Curetis is a molecular diagnostics company focusing on the detection of severe infectious disease in hospitalized patients. Its CE IVD marked Unyvero platform is marketed across Europe and has recently also successfully completed a US FDA trial for its LRT lower respiratory tract infection cartridge.

For more information: www.curetis.com

Download photo